Sara Eyal

3.1k total citations
91 papers, 2.3k citations indexed

About

Sara Eyal is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Sara Eyal has authored 91 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pediatrics, Perinatology and Child Health, 25 papers in Psychiatry and Mental health and 23 papers in Oncology. Recurrent topics in Sara Eyal's work include Pharmacological Effects and Toxicity Studies (41 papers), Epilepsy research and treatment (22 papers) and Drug Transport and Resistance Mechanisms (21 papers). Sara Eyal is often cited by papers focused on Pharmacological Effects and Toxicity Studies (41 papers), Epilepsy research and treatment (22 papers) and Drug Transport and Resistance Mechanisms (21 papers). Sara Eyal collaborates with scholars based in Israel, United States and Italy. Sara Eyal's co-authors include Jashvant D. Unadkat, Peng Hsiao, Miriam Shmuel, Dana Ekstein, Meir Bialer, Boris Yagen, Yoram Altschuler, Amnon Hoffman, Mary F. Hébert and Eran Lavy and has published in prestigious journals such as Journal of Controlled Release, British Journal of Pharmacology and Pharmacology & Therapeutics.

In The Last Decade

Sara Eyal

85 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Eyal Israel 27 859 559 411 384 355 91 2.3k
Xavier Declèves France 39 905 1.1× 1.8k 3.2× 1.1k 2.7× 279 0.7× 279 0.8× 149 4.5k
Mervyn J. Eadie Australia 38 2.4k 2.8× 342 0.6× 380 0.9× 2.0k 5.3× 1.1k 3.1× 246 4.6k
Mladen V. Tzvetkov Germany 31 823 1.0× 1.1k 2.0× 781 1.9× 185 0.5× 196 0.6× 122 3.3k
Salvatore Cisternino France 30 660 0.8× 1.2k 2.1× 778 1.9× 186 0.5× 129 0.4× 124 2.7k
Peter M. Edelbroek Netherlands 29 1.0k 1.2× 493 0.9× 305 0.7× 1.3k 3.4× 179 0.5× 63 3.0k
Lauri Kangas Finland 31 222 0.3× 657 1.2× 919 2.2× 271 0.7× 122 0.3× 162 3.3k
K. Wayne Riggs Canada 24 501 0.6× 221 0.4× 248 0.6× 100 0.3× 418 1.2× 64 1.7k
Jean‐Michel Scherrmann France 42 934 1.1× 2.0k 3.6× 1.6k 3.9× 311 0.8× 180 0.5× 114 5.0k
Bernard L. Mirkin United States 30 589 0.7× 503 0.9× 1.2k 2.8× 99 0.3× 225 0.6× 131 3.1k
Jun He China 22 318 0.4× 212 0.4× 488 1.2× 234 0.6× 95 0.3× 136 1.9k

Countries citing papers authored by Sara Eyal

Since Specialization
Citations

This map shows the geographic impact of Sara Eyal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Eyal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Eyal more than expected).

Fields of papers citing papers by Sara Eyal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Eyal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Eyal. The network helps show where Sara Eyal may publish in the future.

Co-authorship network of co-authors of Sara Eyal

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Eyal. A scholar is included among the top collaborators of Sara Eyal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Eyal. Sara Eyal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Merquiol, Emmanuelle, et al.. (2024). Differential Effect of Simulated Microgravity on the Cellular Uptake of Small Molecules. Pharmaceutics. 16(9). 1211–1211.
4.
Beloosesky, Ron, et al.. (2023). Placental disposition of cannabidiol: An ex vivo perfusion study. Epilepsia. 64(12). 3354–3364. 4 indexed citations
5.
Fahoum, Firas & Sara Eyal. (2023). Intracerebroventricular administration for delivery of antiseizure therapeutics: Challenges and opportunities. Epilepsia. 64(7). 1750–1765. 14 indexed citations
6.
Matok, Ilan, et al.. (2023). The extent of cytochrome P450 3A induction by antiseizure medications: A systematic review and network meta‐analysis. Epilepsia. 65(2). 445–455. 7 indexed citations
7.
Ekstein, Dana, Iris Noyman, Firas Fahoum, et al.. (2020). Treating Epilepsy Patients with Investigational Anti-COVID-19 Drugs: Recommendations by the Israeli Chapter of the ILAE.. PubMed. 11(22). 665–672. 2 indexed citations
8.
Maggio, Nicola, et al.. (2018). Epilepsia – July 2018 – Announcements. Epilepsia. 59(7). 1470–1472. 1 indexed citations
9.
Eyal, Sara, et al.. (2018). The Placental Barrier: the Gate and the Fate in Drug Distribution. Pharmaceutical Research. 35(4). 71–71. 112 indexed citations
10.
Ben‐Hur, Tamir, et al.. (2018). Effects of Valproic Acid on Cerebral Nutrient Carriers' Expression in the Rat. Frontiers in Pharmacology. 9. 1054–1054. 9 indexed citations
11.
Friedman‐Levi, Yael, Liraz Larush, Michèle Diana, et al.. (2017). Optimization of liposomal indocyanine green for imaging of the urinary pathways and a proof of concept in a pig model. Surgical Endoscopy. 32(2). 963–970. 15 indexed citations
12.
Ekstein, Dana, et al.. (2016). Utilization of antiepileptic drugs in Israel. Epilepsy & Behavior. 61. 82–85. 15 indexed citations
13.
Ekstein, Dana, et al.. (2015). Drug interactions involving antiepileptic drugs: Assessment of the consistency among three drug compendia and FDA-approved labels. Epilepsy & Behavior. 44. 218–224. 18 indexed citations
14.
Shmuel, Miriam, et al.. (2015). Indocyanine Green Liposomes for Diagnosis and Therapeutic Monitoring of Cerebral Malaria. Theranostics. 6(2). 167–176. 24 indexed citations
15.
Nizri‏, Eran, et al.. (2015). Imaging the urinary pathways in mice by liposomal indocyanine green. Nanomedicine Nanotechnology Biology and Medicine. 11(5). 1057–1064. 22 indexed citations
16.
Deo, Anand K., Soo Borson, Jeanne M. Link, et al.. (2014). Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood–Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease. Journal of Nuclear Medicine. 55(7). 1106–1111. 155 indexed citations
17.
Ryu, Rachel, Sara Eyal, Henry G. Kaplan, et al.. (2014). Pharmacokinetics of doxorubicin in pregnant women. Cancer Chemotherapy and Pharmacology. 73(4). 789–797. 28 indexed citations
18.
Eyal, Sara, Thomas R. Easterling, Darcy B. Carr, et al.. (2010). Pharmacokinetics of Metformin during Pregnancy. Drug Metabolism and Disposition. 38(5). 833–840. 150 indexed citations
19.
Eyal, Sara, Mark Muzi, J. M. Link, et al.. (2009). Positron emission tomography imaging of tissue P‐glycoprotein activity during pregnancy in the non‐human primate. British Journal of Pharmacology. 159(2). 394–404. 26 indexed citations
20.
Hoffman, Amnon, David Stepensky, Eran Lavy, et al.. (2004). Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. International Journal of Pharmaceutics. 277(1-2). 141–153. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026